← HB3834 bill details

Other recorded roll call

HB3834

House: FOURTH READING

Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.

Passed House May 6, 2026

69Yea
21Nay
0Not voting
9Absent

Yea (69)

Nay (21)

Absent (9)

Open official vote recordOpen LegiScan roll call
Source provenance
LegiScan roll-call ID
1694669
LegiScan bill ID
2082076
Session ID
2219
Individual records rendered
99
Source file
var/states/oklahoma/source/legiscan/2219-befa0395515d/vote/1694669.json
Package observed
2026-07-18T22:26:27+00:00
Final-action classification
Did not match the final-vote patterns; retained as part of the complete bill record.